Class II · Moderate risk
Zinc Chloride
Lack of assurance of sterility.
FDA drug recalls in 2022
Every FDA drug recall initiated in 2022, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,390 recalls, newest first.
Class II · Moderate risk
Vitamin D3
Lack of assurance of sterility.
Class II · Moderate risk
Ultratest Testosterone Cypionate 160 mg/mL Testosterone Propionate 40 mg/mL
Lack of assurance of sterility.
Class II · Moderate risk
Tri-Immune Boost Glutathione 200 mg/mL Ascorbic Acid 200 mg/mL…
Lack of assurance of sterility.
Class II · Moderate risk
Testosterone Cypionate 200 mg/mL in Sesame Oil
Lack of assurance of sterility.
Class II · Moderate risk
Testosterone Cypionate 200 mg/mL in Grapeseed Oil
Lack of assurance of sterility.
Class II · Moderate risk
T-106 Papaverine 30 mg/mL Phentolamine 1 mg/mL Alprostadil 25 mcg/mL
Lack of assurance of sterility.
Class II · Moderate risk
T-105 Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL
Lack of assurance of sterility.
Class II · Moderate risk
Sodium Tetradecyl Sulfate 5% MDV Injection
Lack of assurance of sterility.
Class II · Moderate risk
Sodium Tetradecyl Sulfate 1.5% MDV Injection
Lack of assurance of sterility.
Class II · Moderate risk
Sodium Tetradecyl Sulfate 0.3% Injection
Lack of assurance of sterility.
Class II · Moderate risk
Sodium Selenite 200 mg/mL
Lack of assurance of sterility.
Class II · Moderate risk
Sodium Bicarbonate 8.4% MDV Injection
Lack of assurance of sterility.
Class II · Moderate risk
Diluent for Reconstitution Multi-Dose 10 mL vial
Lack of assurance of sterility.
Class II · Moderate risk
Sermorelin Acetate Lyophilized powder for reconstitution 9 mg Per Multi-Dose Vial
Lack of assurance of sterility.
Class II · Moderate risk
SB-6 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 60 mcg/mL
Lack of assurance of sterility.
Class II · Moderate risk
SB-5 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 50 mcg/mL
Lack of assurance of sterility.
Class II · Moderate risk
RE-2 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 300 mcg/mL
Lack of assurance of sterility.
Class II · Moderate risk
RE-1 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 200 mcg/mL
Lack of assurance of sterility.
Class II · Moderate risk
QM-4 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 300 mcg/mL Atropine 0.2 mg/mL
Lack of assurance of sterility.
Class II · Moderate risk
medroxyPROGESTERone Acetate Injectable Suspension
Lack of assurance of sterility
Class II · Moderate risk
medroxyPROGESTERone Acetate Injectable Suspension
Lack of assurance of sterility
Class II · Moderate risk
medroxyPROGESTERone Acetate Injectable Suspension
Lack of assurance of sterility
Class II · Moderate risk
medroxyPROGESTERone Acetate Injectable Suspension
Lack of assurance of sterility
Class II · Moderate risk
medroxyPROGESTERone Acetate Injectable Suspension
Lack of assurance of sterility